Biotech · Private company
Teclison Ltd.
Track this companyFree. Adds Teclison Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials43 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- Conventional Transarterial Embolization (TAE)Phase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- DoxorubicinPhase 2 · Carcinoma, HepatocellularClinicalTrials.gov · fetched Nov 12, 2026
- Nivolumab Injectable ProductPhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Regorafenib PillPhase 2 · Colorectal Cancer; Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- TAS-102 pillPhase 2 · Colorectal Cancer; Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- TATE and pembrolizumabPhase 2 · Colorectal Cancer; Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- TirapazaminePhase 2 · Carcinoma, HepatocellularClinicalTrials.gov · fetched Nov 12, 2026
- TirapazaminePhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Trans-arterial tirapazamine embolizationPhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- TATE and Pembrolizumab (MK3475) in mCRC and NSCLCPHASE2 · RECRUITING · started May 20, 2021ClinicalTrials.gov NCT04701476 · fetched Nov 12, 2026
- TATE Versus TACE in Intermediate Stage HCCPHASE2 · TERMINATED · started Dec 5, 2017ClinicalTrials.gov NCT03145558 · fetched Nov 12, 2026
- Combination of TATE and PD-1 Inhibitor in Liver CancerPHASE2 · RECRUITING · started Jul 1, 2017ClinicalTrials.gov NCT03259867 · fetched Nov 12, 2026
- Dose-defining Study of Tirapazamine Combined With Embolization in Liver CancerPHASE1_PHASE2 · RECRUITING · started Sep 1, 2014ClinicalTrials.gov NCT02174549 · fetched Nov 12, 2026